ML-236B Derivatives

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D30930

Patent

active

044489790

ABSTRACT:
Compounds of formula (I): ##STR1## (wherein R represents a group of formula ##STR2## and the corresponding ring-closed lactones, salts (especially alkali metal salts) and esters (especially C.sub.1 -C.sub.5 alkyl esters) thereof may be prepared by subjecting ML-236B, or ML-236B carboxylic acid or a salt or ester thereof to enzymatic hydroxylation, which may be effected by means of microorganisms of the genera Mucor, Rhizopus, Zygorynchus, Circinella, Actinomucor, Gongronella, Phycomyces, Martierella, Pycnoporus, Rhizoctonia, Absidia, Cunninghamella, Syncephalastrum and Streptomyces, or cell-free, enzyme-containing extracts from said microorganisms. The compounds are capable of inhibiting biosynthesis of cholesterol and are thus useful in the treatment of hypercholesteraemia.

REFERENCES:
patent: 3983140 (1976-09-01), Endo et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

ML-236B Derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with ML-236B Derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and ML-236B Derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-846682

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.